Quick Heal grants 2.2 lakh stock options to employees

1 min read     Updated on 19 Jun 2026, 01:40 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Quick Heal Technologies granted 2,20,000 stock options to employees under its ESOP Scheme 2021, approved by the Nomination and Remuneration Committee on June 18, 2026. The options are exercisable into equity shares with a face value of ₹10, featuring a split pricing structure of ₹10 and ₹87 per option. Vesting occurs between one and four years, with a three-year window to exercise vested options.

powered bylight_fuzz_icon
43358995

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies has granted 2,20,000 stock options to employees under its ESOP Scheme 2021. The grant was approved by the company's Nomination and Remuneration Committee on June 18, 2026. This move aims to incentivize employees through equity participation, aligning their interests with the growth of the company.

The options are exercisable into 2,20,000 equity shares, each with a face value of ₹10. The pricing structure for the grant is divided into two categories. A total of 2,00,000 options have an exercise price of ₹10 each, while the remaining 20,000 options are priced at ₹87 each. The price of ₹87 represents a 50% discount based on the NSE closing share price on June 17, 2026.

Vesting and Exercise Details

The stock options come with specific vesting and exercise timelines designed to retain talent over the medium term. The options will vest after a minimum period of one year but no later than four years from the date of grant. Once vested, the options can be exercised by the holders to acquire an equivalent number of equity shares upon payment of the exercise price and applicable taxes.

All vested options must be exercised within a maximum period of three years from the date of vesting. This structure provides employees with a defined window to realize the benefits of their options, subject to the terms and conditions of the ESOP Scheme 2021.

Regulatory Compliance

The grant of options has been executed in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was submitted to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The following table summarizes the key details of the grant:

Particulars Details
Total Options Granted 2,20,000
Shares Covered 2,20,000 equity shares of ₹10 each
Exercise Price (2,00,000 Options) ₹10 per option
Exercise Price (20,000 Options) ₹87 per option
Minimum Vesting Period 1 year
Maximum Vesting Period 4 years
Exercise Window Within 3 years of vesting

No options have been exercised, lapsed, or varied in terms at this stage. The company stated that diluted earnings per share calculations are not applicable at this current stage of the grant process.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-1.97%+7.15%-11.72%-32.90%-49.72%-26.37%

How will the issuance of these new options impact Quick Heal's existing shareholding structure and potential dilution?

What is the company's strategy for funding future ESOP grants as it continues to expand its talent pool?

How might this ESOP scheme influence employee retention rates and overall productivity in the coming years?

Quick Heal Technologies
View Company Insights
View All News
like16
dislike

Quick Heal posts Q4FY26 earnings call transcript

0 min read     Updated on 29 May 2026, 04:56 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Quick Heal Technologies Limited has released the transcript of its investor and analyst call for Q4 and FY26, held on May 22, 2026. The document is accessible via the company's investor relations page. The intimation was filed with exchanges on May 28, 2026, under Regulation 30.

powered bylight_fuzz_icon
40644165

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited has released the transcript of its investor and analyst call for the fourth quarter and financial year 2026. The conference call was originally held on Friday, May 22, 2026, at 4:00 PM IST to discuss the company's financial results. The transcript document is now available for stakeholders to review the detailed discussion regarding quarterly and annual performance.

Access Details

The transcript is hosted on the Quick Heal Technologies investor relations page. Interested stakeholders can access the PDF document to review the management's commentary on the financial results.

Parameter Details
Event Q4 and FY26 Earnings Call
Date Held Friday, May 22, 2026
Time 4:00 PM IST
Transcript Link Conference Call Transcript

Regulatory Filing

The intimation regarding the availability of the call transcript was submitted to the stock exchanges on May 28, 2026. The filing was made in compliance with Regulation 30 and was signed by Vikram Dhanani, Compliance Officer of Quick Heal Technologies Limited. The reference number for this correspondence is QHTL/Sec/SE/2026-27/11.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-1.97%+7.15%-11.72%-32.90%-49.72%-26.37%

What are the key growth drivers Quick Heal anticipates for FY27 based on the Q4 and FY26 performance?

How does Quick Heal plan to navigate the competitive cybersecurity landscape in the upcoming fiscal year?

What strategic investments or innovations is the company prioritizing to enhance its market position?

Quick Heal Technologies
View Company Insights
View All News
like20
dislike

More News on Quick Heal Technologies

1 Year Returns:-49.72%